SEARCH

SEARCH BY CITATION

References

  • 1
    Adinoff AD, Hollister JR. Steroid-induced fractures and bone loss in patients with asthma. N Eng J Med 1983; 309: 2658.
  • 2
    Hooyman JR, Melton LJ, Nelson AM, O'Fallon WM, Riggs BL. Fractures after rheumatoid arthritis. A population-based study. Arthritis Rheum 1984; 27: 135361.
  • 3
    Cooper C., Mitchell M., Wickham C.. Rheumatoid arthritis, corticosteroid therapy and the risk of hip fracture. Ann Rheum Dis 1994 (in press).
  • 4
    Hahn TJ, Halstead LR, Baran DT. Effects of short term glucocorticoid administration on intestinal calcium absorption and circulating vitamin D metabolite concentrations in man. J Clin Endocrinol Metab 1981; 52: 111.
  • 5
    Verstraeten A., Dequeker J.. Vertebral and peripheral bone mineral content and fracture incidence in postmenopausal patients with rheumatoid arthritis: effect of low dose corticosteroids. Ann Rheum Dis 1986; 45: 8527.
  • 6
    Spector TD, Hall GM, McCloskey EV, Kanis JA. Risk of vertebral fracture in women with rheumatoid arthritis. Br Med J 1993; 306: 558.
  • 7
    Cummings SR, Black DM, Nevitt MC, Browner W., Cauley J., Ensrud K., Genant HK, Palermo L., Scott J. et al. Bone density at various sites for prediction of hip fractures. Lancet 1993; 341: 7289.
  • 8
    Luengo M., Picado C., Rio LD, Guanabens N., Montserrat JM, Setoain J.. Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study. Thorax 1991; 46: 8036.
  • 9
    Sambrook P., Birmingham J., Kelly P., Kempler S., Nguyen T., Pocock N., Eisman J.. Prevention of corticosteroid osteoporosis - a comparison of calcium, calcitriol, and calcitonin. N Engl J Med 1993; 328: 174752.
  • 10
    Sambrook P., Birmingham J., Kempler S., Kelly P., Eberl S., Pocock N., Yeates M., Eisman J.. Corticosteroid effects on proximal femur bone loss. J Bone Min Res 1990; 5: 121116.
  • 11
    Reid IR, Evans MC, Stapleton J.. Lateral spine densitometry is a more sensitive indicator of glucocorticoid-induced bone loss. J Bone Min Res 1992; 7: 12215.
  • 12
    Garton MJ, Reid DM. Bone mineral density of the hip and of the anteroposterior and lateral dimensions of the spine in men with rheumatoid arthritis - effects of low-dose corticosteroids. Arthritis Rheum 1993; 36: 2228.
  • 13
    Laan RFJM, Buijs WCAM, Vanerning LJTO, Lemmens JAM, Corstens FHM, Ruijs SHJ, Vandeputte LBA, Vanriel PLCM. Differential effects of glucocorticoids on cortical appendicular and cortical vertebral bone mineral content. Calcif Tissue Int 1993; 52: 59.
  • 14
    Packe GE, Douglas JG, Mcdonald AF, Robins SP, Reid DM. Bone density in asthmatic patients taking high dose inhaled beclomethasone diproprionate and intermittent systemic corticosteroids. (Abstract) Thorax 1992; 47: 41417.
  • 15
    Aaron JE, Francis RM, Peacock M., Makins NB. Contrasting microanatomy of idiopathic and corticosteroid-induced osteoporosis. Clin Orthrop Rel Res 1989; 243: 294305.
  • 16
    LoCascio V., Bonucci E., Imbimbo B., Ballanti P., Adami S., Milani S., Tartarotti D., DellaRocca C.. Bone loss in response to long- term glucocorticoid therapy. Bone and Mineral 1990; 8: 3951.
  • 17
    Bressot C., Meunier PJ, Chapuy MC, Lejeune E., Edouard C., Darby AJ. Histomorphometric profile, pathophysiology and reversibility of corticosteroid-induced osteoporosis. Metab Bone Dis Rel Res 1979; 1: 30311.
  • 18
    Lund B., Storm TL, Melsen P., Mosekilde L., Andersen RB, Egmose C., Sorenson OH. Bone mineral loss, bone histomorphometry and vitamin D metabolism in patients with rheumatoid arthritis on long-term glucocorticoid treatment. Clin Rheum 1985; 4: 1439.
  • 19
    Dempster DW, Arlot MA, Meunier PJ. Mean wall thickness and formation periods of trabecular bone packets in corticosteroid-induced osteoporosis. Calcif Tiss Int 1983; 35: 41017.
  • 20
    Eriksen EF, Hodgson SF, Eastell R., Cedel SL, O'Fallon WM, Riggs BL. Cancellous bone remodelling in type I (postmenopausal) osteoporosis: quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels. J Bone Miner Res 1990; 5: 31120.
  • 21
    Caporali R., Gentile S., Caprotti M., Montecucco C.. Serum osteocalcin (bone Gla-protein) and steroid osteoporosis in rheumatoid arthritis. J Rheumatol 1991; 18: 1489.
  • 22
    Godschalk MF, Downs RW. Effect of short-term glucocorticoids on serum osteocalcin in healthy young men. J Bone Miner Res 1988; 3: 11315.
  • 23
    Nielsen HK, Thomsen K., Eriksen EF, Charles P., Storm T., Mosekilde L.. The effects of high-dose glucocorticoid administration on serum bone gamma carboxyglutamin acid - containing protein, serum alkaline phosphatase and vitamin D metabolites in normal subjects. Bone and Mineral 1988; 4: 10513.
  • 24
    Prummel MF, Wiersinga WM, Lips P., Sanders GTB, Sauerwein HP. The course of biochemical parameters of bone turnover during treatment with corticosteroids. J Clin Endocrinol Metab 1991; 72: 3826.
  • 25
    Reid JR, Chapman GE, Fraser TRC, Davies AD, Surus AS, Meyer J., Huq NL, Ibbertson HK. Low serum osteocalcin levels in glucocorticoid-treated asthmatics. J Clin Endocrinol Metab 1986; 62: 37983.
  • 26
    Kotowicz MA, Hall S., Hunder GG, Cedel SL, Mann KG, Riggs BL. Relationship of glucocorticoid dosage to serum bone gla-protein concentration in patients with rheumatologic disorders. Arthritis & Rheumatism 1990; 33 (No. 10): 148791.
  • 27
    Hodsman AB, Toogood JH, Jennings B., Fraher LJ, Baskerville JC. Differential effects of inhaled budesonide and oral prednisolone on serum osteocalcin. J Clin Endocrinol Metab 1991; 72 (No. 3): 53040.
  • 28
    Beresford JN, Gallagher JA, Poser JW, Russell RGG. Production of osteocalcin by human bone cells in vitro. Effects of 1,25(OH)2D3, 24,25(OH)2D3, parathyroid hormone, and glucocorticoids. Metab Bone Dis Rel Res 1984; 5: 22934.
  • 29
    Oikarinen A., Autio P., Vuori J., Vaananen K., Risteli L., Kiistala U., Ristelli J.. Systemic glucocorticoid treatment decreases serum concentrations of carboxyterminal propeptide of type I procollagen and aminoterminal propeptide of type III procollagen. Br J Dermatol 1992; 126: 172178.
  • 30
    Stellon AJ, Webb A., Compston JE. Bone histomorphometry and structure in corticosteroid treated chronic active hepatitis. Gut 1988; 29: 37884.
  • 31
    Lukert BP, Raisz LG. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Int Med 1990; 112: 35264.
  • 32
    Godschalk M., Levy JR, Downs RW. Glucocorticoids decrease vitamin D receptor numbers and gene expression in human osteosarcoma cells. J Bone Miner Res 1992; 7: 217.
  • 33
    Caniggia A., Nuti R., Lore F., Vattimo A.. Pathophysiology of the adverse effects of glucoactive corticosteroids on calcium metabolism in man. J Steroid Biochem 1981; 15: 15361.
  • 34
    Gennari C., Scala C., Imbimbo B., Bernini M., Montagnani M., Nardi P., Fusi L., Avioli LV. Acute changes in urinary radiocalcium following glucocorticoid administration in man. Adv Exp Med Biol 1984; 171: 40715.
  • 35
    Gallagher JC, Aaron JE, Horsman A., Marshall DH, Wilkinson R., Nordin BEC. The crush fracture syndrome in postmenopausal women. Clinics Endocrinol Metab 1973; 2: 293315.
  • 36
    Ali NJ, Capewell S., Ward MJ. Bone turnover during high dose inhaled corticosteroid treatment. Thorax 1991; 46: 16064.
  • 37
    Need AG. Corticosteroids and osteoporosis. Aust NZ J Med 1987; 17: 26772.
  • 38
    Reid IR. Steroid osteoporosis. Calcif Tiss Int 1989; 45: 637.
  • 39
    Marcus R.. Secondary forms of osteoporosis. Disorders of Bone and Mineral Metabolism 1992; 889904.
  • 40
    Suzuki Y.. Mechanism of development of glucocorticoid-induced osteoporosis and its treatment. Intestinal calcium absorption and vitamin D metabolism in patients under glucocorticoid therapy and correction of secondary hyper parathyroidism. Nippon Naibunpi Gakkai Zasshi 1983; 59: 91837.
  • 41
    Lukert BP, Adams JS. Calcium and phosphorus homeostasis in man. Effect of corticosteroids. Arch Intern Med 1976; 136: 124953.
  • 42
    Fukic RF, Kukreja SC, Hargis GK, Bowser EN, Henderson WJ, Williams GA. Effect of glucocorticoids on function of the parathyroid glands in man. J Clin Endocrinol Metab 1975; 40: 1525.
  • 43
    Hahn TJ, Hahn BH. Osteopenia in patients with rheumatic diseases: principles of diagnosis and therapy. Semin Arthritis Rheum 1976; 6: 16588.
  • 44
    Jennings BH, Andersson KE, Johansson SA. The assessment of the systemic effects of inhaled glucocorticosteroids - the effects of inhaled budesonide vs. oral prednisolone on calcium metabolism. Eur J Clin Pharmacol 1991; 41: 1116.
  • 45
    Bikle DD, Halloran B., Fong L., Steinbach L., Shellito J.. Elevated 1,25-dihydroxyvitamin-D levels in patients with chronic obstructive pulmonary disease treated with prednisone. J Clin Endocrinol Metab 1993; 76: 45661.
  • 46
    Luengo M., Picado C., Piera C., Guanabens N., Montserrat J., Rivera J., Setoain J.. Intestinal calcium absorption and parathyroid hormone secretion in asthmatic patients on prolonged oral or inhaled steroid treatment. Eur Resp J 1991; 4: 4414.
  • 47
    Morris HA, Need AG, O'Loughlin PD, Horowitz M., Bridges A., Nordin BEC. Malabsorption of calcium in corticosteroid- induced osteoporosis. Calcif Tiss Int 1990; 46: 3058.
  • 48
    Colette C., Monnier L., Herbute NP, Blotman F., Mirouze J.. Calcium absorption in corticoid treated subjects: effects of a single oral dose of calcitriol. Horm Metab Res 1987; 19: 3358.
  • 49
    Reid IR, Ibbertson HK. Evidence for decreased tubular reabsorption of calcium in glucocorticoid-treatment asthmatics. Horm Res 1987; 27: 2004.
  • 50
    Crilly RG, Cawood M., Marshall DH, Nordin BE. Hormonal status in normal, osteoporotic and corticosteroid-treated postmenopausal women. J Roy Soc Med 1978; 71: 7336.
  • 51
    Hseuh AJ, Erickson GF. Glucocorticoid inhibition of FSH-induced estrogen production in cultured rat granulosa cells. Steroids 1978; 32: 63948.
  • 52
    Messina OD, Barreira JC, Zanchetta JR, Maldonadococco JA, Bogado CE, Sebastian ON, Flores D., Riopedre AM, Redondo G. et al. Effect of low doses of deflazacort vs. prednisone on bone mineral content in premenopausal rheumatoid arthritis. J Rheumatol 1992; 19: 152026.
  • 53
    Riggs BL, Melton LJ III. The prevention and treatment of osteoporosis. New Eng J Med 1992; 327: 62027.
  • 54
    Storm T., Thamsborg G., Steiniche T., Genant HK, Sorensen OH. Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. New Eng J Med 1990; 332 (No. 18): 126571.
  • 55
    Mulder H., Struys A.. Intermittent cyclical etidronate in the prevention of steroid-induced bone loss. Br J Rheumatol 1994; 33: 34850.
  • 56
    Reid IR, Schooler BA, Stewart AW. Prevention of glucocorticoid-induced osteoporosis. J Bone Miner Res 1990; 5: 61923.
  • 57
    Reid IR, King AR, Alexande CJ, Ibbertson HK. Prevention of serioid-induced osteoporosis with (3-amino-hydroxypropylidene)-1,1, disphosphonate (APD). Lancet 1988; i: 1436.
  • 58
    Gallagher SJ, Fenner JAK, Anderson K., Bryden FM, Banham SW, Logue FC, Cowan RA, Boyle IT. Intravenous pamidronate in the treatment of osteoporosis associated with corticosteroid dependent lung disease: an open pilot study. Thorax 1992; 47: 9326.
  • 59
    Adachi JD, Cranney A., Goldsmith CH et al. Intermittent cyclic therapy with etidronate in the prevention of corticosteroid-induced bone loss. Can J Rheumatol 1994; 21: 19226.
  • 60
    Lukert BP, Johnson BE, Robinson RG. Estrogen and progesterone replacement therapy reduces glucocorticoid-induced bone loss. J Bone Miner Res 1992; 7: 10639.
  • 61
    Gram J., Bollerslev J., Nielsen HK, Junker P.. Increased serum concentrations of type-I procollagen C-terminal propeptide and osteocalcin during a short course of calcitriol administration to adult male volunteers. Acta Endocrinol 1991; 125: 60913.
  • 62
    Hahn TJ, Halstead LR, Teitelbaum SL. Altered mineral metabolism in glucocorticoid-lnduced osteopenia: Effect of 25-hydroxyvitamin D administration. J Clin Invest 1979; 64: 65565.
  • 63
    Bijlsma JWJ. Bone metabolism in patients with rheumatoid arthritis. Clin Rheum 1988; 7 (No. 1): 1623.
  • 64
    Montemurro L., Schiraldi G., Fraioli P., Tosi G., Riboldi A., Rizzato G.. Prevention of corticosteroid-induced osteoporosis with salmon calcitonin in sarcoid patients. Calcif Tiss Int 1991; 49: 716.